Author

S. R. Ferdosi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:multiome· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

B. Taylor· 1 shared F. Furnari· 1 shared F. Moghadam· 1 shared G. Reid· 1 shared H. D. Dhruv· 1 shared J. G. Park· 1 shared K. Garcia-Mansfield· 1 shared K. S. Anderson· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Taylor

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 21, 2020

Dynamic multi-OMICs of glioblastoma reveal sensitivity to neddylation inhibition dependent on nuclear PTEN and DNA replication pathways

S. R. Ferdosi, B. Taylor, M. Lee…·M. E. Berens

The paper investigates the dynamic multi-OMICs of glioblastoma and identifies sensitivity to neddylation inhibition, though the manuscript was withdrawn due to un reproducible findings.

DOI 10.1101/2020.07.21.212571

humanmultiome

𝕏 PostBluesky

ImmunologybioRxivJul 2, 2018

Multifunctional CRISPR/Cas9 with engineered immunosilenced human T cell epitopes

S. R. Ferdosi, R. Ewaisha, F. Moghadam…·K. S. Anderson

This study shows that Cas9 can be modified to reduce immunogenicity while maintaining its function.

DOI 10.1038/s41467-019-09693-x

humanexperimental assay

𝕏 PostBluesky